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Contemporary management of vascular
complications associated with Ehlers-Danlos
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Benjamin S. Brooke, MD,a George Arnaoutakis, MD,a Nazli B. McDonnell, MD, PhD,b and
James H. Black III, MD,a Baltimore, Md
Objectives: There has been debate regarding the safety of performing elective procedures in patients with vascular
manifestations associated with Ehlers-Danlos syndrome (EDS). The purpose of this study was to review the surgical
management and clinical outcomes of EDS patients undergoing vascular procedures at a tertiary medical center with
multimodality expertise in connective tissue disorders.
Methods: All patients with EDS undergoing endovascular and open vascular procedures at a single-institution academic
medical center from 1994 to 2009 were retrospectively reviewed. Clinical data were evaluated including patient
demographics, length of stay (LOS), and mortality outcomes during hospital course and long-term follow-up.
Results: A total of 40 patients with EDS were identified, including individuals diagnosed with classic (n  15),
hypermobility (n  16), and vascular (n  9) types of EDS. These patients collectively underwent 45 endovascular and
18 open procedures for vascular disease during the time period, including embolization (n  37), angioplasty (n  8),
arterial bypass (n  5), and aortic aneurysm repair (n  13). All cases were performed electively, except for one (2%)
urgent endovascular and one (5%) emergent open procedure. Endovascular procedures were associated with a median
LOS (interquartile range [IQR]) of 2 (1 to 3) days with no procedure-related mortality or in-hospital deaths among all
EDS types, whereas open vascular procedures had median LOS (IQR) of 6 (5 to 8) days with one (6%) in-hospital death
occurring in a vascular EDS patient. Survival free of any complication at 5 years was 85% and 54% following endovascular
and open procedures, respectively.
Conclusions: The elective surgical management of vascular disorders in EDS patients using open and endovascular
procedures has been associated with good outcomes. Our results suggest that vascular interventions in these EDS patients
can be safely performed and should not be withheld until rupture or acute symptoms arise. ( J Vasc Surg 2010;51:131-9.)Ehlers-Danlos syndrome (EDS) is a group of clinically
and genetically heterogeneous heritable connective tissue
disorders resulting from mutations in genes involved in
extracellular matrix formation and organization, leading to
a predisposition for loss of structural integrity in tissues
within multiple organ systems.1 While six different forms
of EDS are currently recognized, including classical, hy-
permobile, kyphoscoliotic, arthrochalasic, and dermato-
sparactic types, the vascular type (formerly EDS IV) is the
most severe form of the disorder.2 Disease-related symp-
toms vary based on each EDS type, but are generally
characterized by joint hypermobility, skin hyperextensibil-
ity, and tissue fragility affecting skin, ligaments, joints,
internal organs, and blood vessels.3
Vascular manifestations are among the most severe
complications of EDS and involve a spectrum of arterial and
venous anomalies, including progressive aneurysm forma-
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vascular type EDS patients are generally recognized as
having the most severe complications, vascular disease can
present in many types of EDS patients. While it is likely that
any given EDS patient will require a vascular procedure at
some point during their lifetime, there is ongoing debate
regarding the optimal surgical management of these pa-
tients.4-7 There is limited awareness about the distinctions
among the different types of EDS and their cardinal mani-
festations in surgical patients. Since the historical experi-
ence detailing high complication rates and surgical failures
in vascular type EDS patients is often taken as representa-
tive of the whole group,4-7 many elective vascular proce-
dures are deferred or declined in EDS patients, thereby
inviting significant and potentially unwarranted anxieties
into the patient-doctor relationship. The objective of this
study is to review the contemporary surgical management
and clinical outcomes of EDS patients at a medical center
with multimodality expertise in treating connective tissue
disorders.
METHODS
Study patients
All patients diagnosed with EDS who were treated at
the Johns Hopkins Hospital in Baltimore, Maryland be-
tween January 1994 and December 2008, were identified
from an institutional database. Permission to review patient
records was granted following Institutional Review Board
approval. Cases were retrospectively identified by using the
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for EDS (756.83) and the specific subtype diagnosis was
confirmed by reviewing the medical history, clinical fea-
tures of disease, and radiology imaging studies. Diagnostic
criteria for EDS were defined using the revised nosology of
Villefranche, and all patients were categorized into specific
EDS subtypes based on this modern classification system.8
Confirmation of subtype diagnosis was made using results
of biochemical testing of skin biopsy for collagen typing or
genetic mutation analysis whenever applicable data were
available.
Hospital and longitudinal data pertaining to all en-
dovascular or open vascular surgical procedures under-
taken at the Johns Hopkins Hospital in identified EDS
patients were extracted for analysis. This included vascular
procedures performed by vascular surgeons, cardiothoracic
surgeons, and interventional radiologists. Therapeutic de-
cision making for the EDS patients was guided by interac-
tions among the treating surgeon or interventionalist in
concert with medical geneticists with extant expertise in
management of connective tissue disorders. In addition,
the results of all preoperative and postoperative radiology
imaging (CT, MRI, angiography) studies were reviewed
and used to confirm patient diagnosis and procedure un-
dertaken.
Study variables. Patient demographics and character-
istics associated with EDS symptoms were collected from a
careful review of paper and electronic patient records. Vari-
ables extracted included age at diagnosis, age at time of first
operation, age at time of elective vascular procedure, gen-
der, race, smoking history, and EDS subtype. In addition,
records were reviewed to ascertain whether a family history
of EDS, sudden death, or early onset of severe cardiovas-
cular disease existed. The age and specific diagnosis of
first-degree relatives with EDS symptoms were collected, as
well as their reported outcomes.
Operative data were collected from a review of anesthe-
sia and operative notes. Variables collected for analysis
included the specific type of procedure, whether the proce-
dure was converted from percutaneous to open, and esti-
mated blood loss. Moreover, the total number of units of
blood products received during patients’ hospital stay was
extracted from a review of blood bank records and catego-
rized by the number of units of packed red blood cells
(PRBC), fresh frozen plasma (FFP), or platelets transfused.
Several outcome variables were collected to assess the
morbidity and mortality related to elective vascular surgery
in EDS patients. The main in-hospital outcome measures
were operative mortality, in-hospital mortality, major com-
plications, and median length of hospital stay following
elective endovascular and open vascular surgery proce-
dures. Late follow-up data and outcomes related to death
or need for secondary vascular procedures were obtained
from medical records, office visits, and the national death
index.
Statistical analysis. Differences between EDS pa-
tients and study outcomes were compared using one-way
analysis of variance (ANOVA) or the Wilcoxon rank-sumtest for continuous variables and the Kruskal-Wallis test or
Fisher’s exact test for categorical data. Survival curves were
calculated using the Kaplan-Meier method. P values less
than .05 were considered to be statistically significant for all
tests and models. All statistical analyses were perfomed
using Stata statistical software, version 9.1 (StataCorp,
College Station, Tex).
RESULTS
A total of 183 patients with EDS were identified that
underwent treatment for a broad range of medical condi-
tions at the Johns Hopkins Hospital between 1994 and
2009. Among these EDS patients, 40 (22%) were admitted
and underwent at least one elective endovascular or open
vascular procedure during this defined time period. Patient
characteristics and demographic data for these 40 individ-
uals are shown in Table I. Briefly, this cohort primarily
consisted of female patients (82%) of Caucasian descent
(95%), with a median age of 34 years at the time of their
elective procedure. Fifteen patients (37%) met diagnostic
criteria for classical EDS, 16 (40%) met diagnostic criteria
for hypermobility EDS, and nine patients (23%) met diag-
nostic criteria for vascular EDS. Only 12 (31%) patients
within this cohort were found to have a known family
history of EDS or early cardiovascular disease, and six (16%)
additional patients had a family history of sudden death of
unknown etiology.
Endovascular procedures. Forty-five endovascular
procedures were undertaken in EDS patients, including 15
(33%) in patients with classic EDS, 27 (60%) in patients
with hypermobility EDS, and three (7%) in patients with
Table I. Characteristics and demographics of EDS
patients (n  40) undergoing elective vascular procedures
Variable Value
Age – median (IQR)
Age at EDS diagnosis 25 (16-39)
Age at time of first vascular procedure* 34 (22-40)
Gender – No. (%)
Male 7 (17)
Female 33 (82)
Race – No. (%)
Caucasian 38 (95)
African American 2 (5)
EDS subtype
†
– No. (%)
Classical 15 (37)
Hypermobile 16 (40)
Vascular 9 (23)
Other EDS subtypes 0 (0)
Family history – No. (%)
History of EDS 12 (31)
History of sudden death 6 (16)
History of early CV disease 12 (31)
CV, Cardiovascular; EDS, Ehlers-Danlos syndrome; IQR, interquartile
range; No., number.
*Median age at which patients underwent their first endovascular or open
vascular procedure.
†EDS classification defined using the revised nosology of Villefranche.vascular EDS (Table II). All endovascular procedures were
pitaliz
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in a patient with vascular EDS. Arterial and venous embo-
lizations were the most common type of endovascular
procedure performed among patients in all three EDS
diagnostic subgroups (N  37 embolization procedures).
Embolization materials included scleroembolization by
gelfoam and sodium morrhuate in 34 of the procedures
(92%) or coils in 24 procedures (65%). Twenty-one proce-
dures (57%) were performed using both coils and sclero-
embolization material, and only three procedures (8%)
used coils alone (which was in arterial locations only).
Angioplasty ( stenting) was undertaken for arterial steno-
sis in five procedures in patients with classic EDS (two
primary subclavian angioplasty, one secondary subclavian
angioplasty, and two primary renal artery angioplasty pro-
cedures). Three procedures were performed in patients
with hypermobility EDS for vein stenosis associated with
DVT. None of these percutaneous procedures were per-
formed in patients with vascular EDS. While patients with
vascular EDS were significantly more likely (P  .05) to
require general anesthesia during endovascular procedures
Table II. Operative data for EDS patients (n  40) under
Endovascular p
Variable
Classic EDS
(n  15)
Procedure type – No. (%)
Embolization 10 (67)
Angioplasty 5 (33)
Anesthesia type – No. (%)
General 0 (0)
CS/local 15 (100)
Conversion to open – No. (%) 0 (0)
Blood products
§
– median (IQR)
PRBC (units) 0 (0)
FFP (units) 0 (0)
Platelets (6 packs) 0 (0)
Open vascular
Variable
Classic EDS
(n  7)
Procedure type – No. (%)
Arterial bypass
†
3 (42)
TAAA repair (Crawford I-III) 2 (29)
AAA repair (Crawford IV) 2 (29)
Anesthesia type – No. (%)
General 7 (100)
CS/local 0 (0)
EBL (L) – median (IQR) 1 (0.3-4.0)
Blood products
§
– median (IQR)
PRBC (units) 2 (0-4)
FFP (units) 0 (0-4)
Platelets (6 packs) 0 (0-0)
AAA, Abdominal aortic aneurysm; CS/local, combined conscious sedation
FFP, fresh frozen plasma; IQR, interquartile range; No., number; PRBC, p
*P value calculated using the Kruskal-Wallis test for categorical data and on
†Includes peripheral and reno visceral arterial bypass procedures.
§Number of units of blood products transfused during entire course of hosdue to surgeon or interventionalist preference, neverthe-less, there were no conversions to open procedures or need
to transfuse blood products in EDS patients within any
diagnostic subgroups (Table II). Open femoral access was
performed in all cases of patients with vascular type EDS
with repair and reinforcement of access site punctures using
suture repair and felt pledget and/or buttressing.
In-hospital outcomes for EDS patients undergoing elec-
tive endovascular and open vascular procedures are shown in
Table III. There were no operative or in-hospital deaths
following endovascular procedures among EDS patients be-
longing to the three diagnostic subtypes. Moreover, no sig-
nificant differences were found in median LOS or rate of
major postoperative complications following endovascular
procedures between EDS patients belonging to any of the three
diagnostic subgroups. There were no perioperative complica-
tions (including bleeding) associated with endovascular proce-
dures, except for a transient bradycardic episode experiencedby a
single patient undergoing embolization with hypermobile EDS
that responded with pharmacologic agents.
Long-term outcomes in patients undergoing elective
endovascular procedures were obtained in all but three
g elective endovascular and open vascular procedures
ures (n  45)
Hypermobile EDS
(n  27)
Vascular EDS
(n  3) P value*
.52
24 (89) 3 (100)
3 (11) 0 (0)
.05
2 (7) 2 (67)
25 (93) 1 (33)
0 (0) 0 (0) 1.0
0 (0) 0 (0) 1.0
0 (0) 0 (0) 1.0
0 (0) 0 (0) 1.0
ures (n  18)
Hypermobile EDS
(n  2)
Vascular EDS
(n  9) P value*
.05
2 (100) 0 (0)
0 (0) 5 (55)
0 (0) 4 (45)
1.0
2 (100) 9 (100)
0 (0) 0 (0)
0.4 (0.2-0.6) 9 (3-21) .05
1 (0-2) 8 (4-26) .07
0 (0-0) 6 (4-19) .05
0 (0-0) 2 (1-4) .05
ocal anesthesia; EBL, estimated blood loss; EDS, Ehlers-Danlos syndrome;
red blood cells; TAAA, thoracoabdominal aortic aneurysm.
analysis of variance for continuous variables.
ation.goin
roced
proced
and l
acked
e-wayindividuals who were lost to follow-up. The median
e dura
JOURNAL OF VASCULAR SURGERY
January 2010134 Brooke et alfollow-up of all EDS patients undergoing endovascular
procedures was 1.6 (range, 0.5-9) years, with no re-
ported deaths. Cumulative survival free of any complica-
tion was 85% at 5 years (see Fig 1); only one vascular
complication occurred in a patient who presented with a
ruptured right hepatic artery aneurysm and intraparency-
mal liver hematoma 2.5 years after her index operation, a
splenic artery embolization (see Fig 2). This complication
was successfully treated by selective coil embolization of the
right hepatic artery branch, and the patient recovered with-
out any further vascular events to present. Notably, the
appreciated hepatic aneurysms developed within the 2.5-
year time frame, as high-quality axial and 3D imaging
Table III. In-hospital outcomes for elective endovascular
Endovascular p
Outcome
Classic EDS
(n  15)
Operative death – No. (%) 0 (0)
In-hospital death – No. (%) 0 (0)
LOS – median (IQR) 1 (1-2)
Any complication
†
– No. (%) 0 (0)
Open vascular
Outcome
Classic EDS
(n  7)
Operative death – No. (%) 0 (0)
In-hospital death – No. (%) 0 (0)
LOS – median (IQR) 7 (5-8)
Any complication
†
– No. (%) 3 (29)
EDS, Ehlers-Danlos syndrome; FFP, fresh frozen plasma; IQR, interquartil
*P value calculated using the Kruskal-Wallis test.
†Any major complications occurring during the perioperative period and th
Fig 1. Kaplan-Meier estimates of cumulative survival free of any
vascular complication among 40 patients with Ehlers-Danlos syn-
drome (EDS) who underwent 45 endovascular (dashed line) and
17 open vascular procedures (solid line). SEM  10% after 4 years
for open procedures and after 3 years for endovascular procedures.demonstrated normal hepatic vasculature earlier.Open vascular procedures. Eighteen open vascular
procedures were performed in EDS patients, including
seven (39%) in patients with classical EDS, two (11%) in
patients with hypermobility EDS, and nine (50%) in pa-
tients with vascular EDS (Table II). All cases were elective,
with the exception of one (6%) emergent TAAA repair in a
patient with vascular EDS. Peripheral or visceral arterial
bypass procedures were more frequently performed in clas-
sical and hypermobility EDS patients within our cohort,
whereas vascular EDS patients were more likely to undergo
thoracoabdominal aortic aneurysm (TAAA) repair and ab-
dominal aortic aneurysm (AAA) repair procedures (P 
open vascular procedures in EDS patients (n  40)
ures (n  45)
permobile EDS
(n  27)
Vascular EDS
(n  3) P value*
0 (0) 0 (0) 1.0
0 (0) 0 (0) 1.0
2 (1-2) 3 (1-6) .51
1 (4) 0 (0) .37
ures (n  18)
ypermobile EDS
(n  2)
Vascular EDS
(n  9) P value*
0 (0) 1 (11) .61
0 (0) 1 (13) .56
5 (2-8) 7 (6-8) .86
0 (0) 3 (38) .58
e; LOS, length of stay; No., number.
tion of hospital stay.
Fig 2. Reconstruction of abdominal CT angiography scan show-
ing a ruptured right anterior hepatic arterial aneurysm and associ-
ated hemoperitoneum in a patient with vascular Ehlers-Danlos
syndrome (EDS) who presented with 2.4 years following suc-
cessful elective coil embolization of a splenic artery aneurysm.and
roced
Hy
proced
H
e rang.05). Correspondingly, estimated blood loss during open
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patients, and they received a higher number of blood
product transfusions during the entire course of their hos-
pital stay (Table II), but this was certainly reflective of the
greater extent of arterial replacement. All arterial recon-
struction procedures in vascular EDS patients were under-
taken using Teflon or felt reinforcement at the anasta-
moses.
Elective open vascular procedures were successfully
undertaken in all three EDS diagnostic subgroups, with
only one operative and in-hospital death occurring in a
vascular EDS patient undergoing a juxtarenal AAA repair
(Table III). Likewise, there was no significant difference in
median LOS or the in-hospital complication rate between
EDS patients in the three diagnostic subgroups. Postoper-
ative complications experienced in classical EDS patients
included an incisional hernia and pneumothorax in one
patient and an episode of atrial fibrillation in a second
patient. Complications following open procedures in vas-
cular EDS included a sternal hematoma requiring washout
and draining in one patient and a thoracic duct injury with
chylous leak during proximal descending thoracic aortic
repair that was managed conservatively with parenteral
nutrition for 2 weeks and gradual introduction of oral
intake.
Long-term follow-up was obtained in all EDS pa-
tients undergoing open vascular procedures. The median
follow-up in this group of patients was 3.2 (range, 1-11)
years. One death occurred in a patient 4.2 years after a
suprarenal AAA repair, although the exact cause of mor-
tality could not be determined. While there were no late
graft-related complications or anastomotic aneurysms
found on follow-up imaging, three patients developed an-
eurysms in noncontiguous aortic segments that required
further elective operative repair. The overall survival free of
any complication was 54% at 5 years and 42% at 10 years, as
vascular events predominated the later complications (89%)
over other gastrointestinal or orthopedic complications
(11%) referable to the disorders.
DISCUSSION
EDS is a heterogeneous disorder with an estimated
prevalence of 1:5000 to 1:25,000 births.2,3 The relative
frequencies of different EDS types are not known precisely,
but classical and hypermobile types account for 90%. In
comparison, vascular EDS likely accounts for less than 5%
of EDS patients.2 The classification of EDS is first made on
clinical grounds using the major and minor criteria defined
by the Villefranche nosology8 and substantiated by bio-
chemical and molecular analysis when possible. The classi-
cal, hypermobile, and vascular types of EDS are autosomal
dominant disorders, and affected individuals have a 50%
risk of passing the disorder to offspring. Nonetheless, many
features of EDS may not be recognized until adulthood.
Confounding issues include the high incidence of joint
laxity in young children in the normal population9 and
frequent bruising in active youngsters. In addition, many
affected persons do not develop widened scars until theyhave sustained an injury that results in skin laceration.
Delays in recognition of the disorder until the occurrence
of an arterial catastrophic event are common. Indeed, only
31% of our patients had an antecedent family history and
prior reports of vascular type patients presenting with arte-
rial complications revealed the patient was aware of their
EDS in only 4% to 26% of cases.4,7 Therefore, clinical
awareness of the treating physician to consider the EDS
diagnosis in patients with findings suspicious for connective
tissue disorder is of utmost importance.
Genotype-phenotype correlation remains elusive, and lo-
cation of the genetic mutation within the collagen genes
(Classical: COL5A1 and COL5A2; Hypermobile: COL5A1
and Tenascin X; Vascular: COL3A1) has not been informa-
tive to predict tissue integrity. In molecular analysis of
COL3A1 genes from 135 vascular type patients, Pepin et
al10 revealed point mutations in most of the subjects that
led to substitution of some other amino acid for glycine
through the triple-helical collagen domain, and no single
mutation correlated with the type or frequency of vascular
complications. Biochemically, since the procollagen mole-
cule is a homopolymer consisting of three identical chains,
only 1/8 of the assembled molecules would be normal if
the pool of procollagen chains contained equal numbers of
normal and mutant chains, as one would expect in het-
erozygous mutation that left only one normal allele. The
7/8 abnormal collagen molecules might be retained or
degraded in a process called “protein suicide.”11 This the-
oretical biochemical explanation has proven operant in
many of the EDS spectrum. Indeed the amount of collagen
deposited in the skin and vessels of vascular type and
classical type patients may be as low as 10% to 15% of
normal.2,12 Moreover, there is evidence that mutation in
one type of collagen gene may interfere with the organiza-
tion and correct assembly of other types of collagens,
making it difficult to predict the impact of a specific muta-
tion in tissue integrity.13 Tensile strength of the skin is
similarly unable to be correlated with genotype but may
correlate with severity of disease.14 There are no available
studies to correlate tensile strength of the skin with a
patient’s capacity to tolerate surgery or to model a periop-
erative risk analysis.
Endovascular approaches to coil embolize aortic branch
vessels and other medium sized-arteries have been successful
in EDS patients in our contemporary experience and that of
others.7,15-17 Historical estimates of mortality related to
arteriography in vascular type EDS ranged up to 17%, with
67% of patients experiencing major complications.4,18 We
believe the excessive rate of arterial complication was re-
lated to large-diameter sheaths and devices used in prior
decades. Modern endovascular technology has evolved to
lower-profile systems with less traumatic catheters and
wires. Nonetheless, arterial access can precipitate femoral
rupture and pseudoaneurysm formation, especially when
large devices are necessary. Consideration should be given
to open repair of any access puncture, especially when a
larger French size is introduced (see Fig 3). Indeed, an
endovascular suite with hybrid abilities to perform both
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most patients with arterial aneurysm interventions, and we
have used this setting in the past 5 years for all patients with
classical and vascular type EDS arterial aneurysm emboliza-
tions.
Stent-graft therapy for abdominal or thoracic aortic
aneurysm in EDS has not been reported in significant
samples and with no long-term follow-up.19 Clearly, the
long-term durability and threat to the fixation zones in the
setting of chronic outward radial force of the device against
an abnormal host vessel may increase secondary interven-
tions. Emerging reports suggest stent-graft therapy in con-
nective tissue disorders may be wrought with complications
with perforation and erosion at fixation zones and very high
rates of secondary reintervention.18,19 As such, we are in
agreement with recent consensus documents that stent-
graft therapy in EDS patients (and those with other con-
nective tissue disorders) should be avoided.20 Recent liti-
gation suggests physician reliance on consensus statements
to determine medically reasonable levels of care in patients
Fig 3. Technique for management of the access vessel in fragile
vasculature of Ehlers-Danlos syndrome (EDS) patient. (A) A “U”
stitch monofilament suture is placed with a pledget buttress, and
needle entry is made within the area. (B) Sheath access is obtained
and manipulated or exchanged minimally to avoid femoral tears.
(C) The pledgetted “U” stitch suture is tied down as sheath is
removed. (D) Circumferential felt reinforcement is approximated
to reduce systolic pulse wave stretch on sutures and to prevent late
pseudoaneurysm formation.with cardiovascular abnormalities is very appropriate.21Open surgical therapy of EDS is associated with ele-
vated rates of intraoperative and postoperative complica-
tions.7,18 Prior reports have estimated open mortality in
vascular reconstruction in vascular type patients to be be-
tween 20% to 65%.4-7 Most importantly, regardless of EDS
subtype, we found the vessels display marked thinness and
abnormal handling characteristics, being prone to develop
adventitial hematoma and dissection. Again, this suggests
the type of EDS disorder and its mutation (genotype-
phenotype relationship) was less relevant than the clinical
history of fragile tissues. Our technique of repair in elective
cases included induced hypotension (usually systolic pres-
sure 70 mm Hg to 90 mm Hg) during all clamping
sequences, wide exposure to re-clamp for anastomotic
bleeding across a new, more proximal segment of vessel
thus avoiding repeated clamp application on the same
segment, and circumferential felt reinforcement where pos-
sible. For central cardioaortic operations, hypothermic
circulatory arrest was employed in all cases. Anesthesia
preparation includes large-bore venous access placed under
ultrasound guidance to reduce inadvertent arterial punc-
tures. Our immediate surgical results compare very favor-
ably with the extant surgical literature,4-7 with less opera-
tivemortalities (N 1, 8%) and postoperative hemorrhages
(N  1, 8%). Our appreciably improved surgical results
demonstrate our approach to address the EDS patients
electively, and only two of 15 patients (13%) underwent
procedures for urgent or emergent indication. There were
also three patients who underwent secondary open vascular
procedures on vessels noncontiguous with the original
operation in an elective fashion. This contrasts strongly
with the experience of Oderich et al7 wherein 70% of the
patients had an open operation performed on an emergent
or urgent basis, with 47% performed for rupture with active
bleeding. For each EDS patient presenting acutely (N 2,
both vascular type: patient 1, liver rupture from hepatic
aneurysm, and patient 2, aortic arch rupture with hypoten-
sion), patient 1 had a prolonged hospital stay, and patient 2
experienced a postoperative hematoma requiring explora-
tion.
Hereditable connective tissue disorders such as EDS
are associated with an increased lifelong risk of developing
progressive vascular complications and sudden death. As
shown in Fig 1, approximately 50% of EDS patients in our
cohort who underwent open vascular procedures had died
or presented with a secondary vascular complication after
their elective index case. None of these complications was
related the index surgical anastomosis, and noncontiguous
vessels were the site of event.We continue to follow all EDS
patients closely with regular annual or semiannual radiol-
ogy studies, typically using either computed tomography
angiography or magnetic resonance angiography whole-
body imaging, to detect asymptomatic vascular pathology.
It is important to recognize vascular disease in these pa-
tients early in order to allow preparation for elective surgery
and be able to intervene when patients have the best risk
profile. Indeed, our center’s experience is that each EDS
patient’s operative risk is individualized and may even be
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cal procedures. On the other hand, as EDS patients age, we
also recognize their tissue integrity and ability to tolerate
surgical procedures may wane.
The limitations of the study include the demographic
of a tertiary referral population that may bias the population
to improve our results-patients die before referral or are not
referred at all given severe clinical history. Typical of any
genetic disease, alternatively, referral bias may also overes-
timate treatment risk – less-affected patients are not re-
ferred or even clinically diagnosed before undergoing vas-
cular procedures in their own locale. In general, the rarity of
EDS in the community, as well as the rarity of needing
repair (less than three per year in our tertiary center on
average), should invoke consideration of referral to special-
ized centers with surgeons, interventionalists, and medical
geneticists with expertise in evaluation of connective tissue
disorder patients.
We rely strongly on clinical criteria for diagnosis, yet
biochemical and genetic testing for collagen abnormalities
is more accurate in most cases. It is possible that some of
our study patients were misclassified as having EDS but
may have another disorder. Particularly for the vascular type
patients, three out of nine did not have biochemical or
molecular confirmation. We have reviewed imaging on
these patients and do not appreciate the carotid and verte-
bral tortuosity typical of Loeys-Dietz syndrome or sugges-
tive skeletal anthropometrics. In Loeys-Dietz syndrome,22
peripheral aneurysms and aggressive clinical behaviors are
common, yet surgical handling is known to be very favor-
able versus EDS patients.
Our study included many EDS subjects from all three
of the common subtypes. In the previous literature, arterial
complications have been underreported in nonvascular
type EDS. We contend that genotype-phenotype correla-
tions in EDS are not relevant in the surgical results, as tissue
characteristics are noticeably abnormal in our experience
with themany subtypes. Nonetheless, longer follow-up will
be required to ascertain if our vascular reconstructions,
neighboring portions of the arterial tree, and survival are
distinguishable among the EDS subtypes who suffer vascu-
lar complications.
There remains no effective medical therapy for EDS.
Our data suggest that EDS patients can safely undergo
elective operations, including both endovascular and open
vascular repair procedures. Our approach includes a multi-
disciplinary approach to evaluate the patients by a skilled
medical geneticist, proper anesthetic preparation, and lib-
eral use of adjunctive techniques to reduce operative
trauma in the open and endovascular setting. For patients
presenting with vascular complications amenable to coil
embolization, endovascular approaches demonstrate an ex-
cellent safety profile. We remain committed to open surgi-
cal reconstruction for EDS patients when the nature of the
vascular event requires, and refrain from stent-graft therapy
given the serious nature of the associated fixation zone
complications and high rates of reintervention appreciated
by others.CONCLUSION
Our contemporary results suggest that the majority of
EDS patients with vascular disease can be managed elec-
tively with minimal morbidity and mortality. Prior recom-
mendations to defer vascular interventions in EDS patients
with known vascular abnormalities until urgent or emer-
gent presentation may not be warranted. Further research
to determine tissue integrity and suitability for surgical
handling is likely to aid accurate risk stratification for treat-
ment planning. Referral of EDS patients with vascular
manifestations to centers with experience in the diagnosis
and treatment of patients with connective tissue disorders
should be encouraged.
This study was supported, in part, by funds originating
at the Intramural Program, National Institutes on Aging,
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Dr Charles Brantigan (Denver, Colo). I’d like to know how
you made the diagnosis of the various types of Ehlers-Danlos. Was
the diagnosis based on genetic testing, or was it based on clinical
presentation? If you’re faced with a patient with what looks like
Ehlers-Danlos syndrome that might need a vascular procedure,
what further diagnostic tests are needed?
Dr Brooke.When vascular surgeons are referred patients with
Ehlers-Danlos, there is usually a lot of confusion as to how to
distinguish the different subtypes. However, most patients can be
reliably diagnosed solely on clinical grounds using the revised
diagnostic criteria from the nosology of Villefranche. If a diagnosis
of vascular type Ehlers-Danlos needs to be confirmed, skin biopsies
can be obtained to assay the amount of type III collagen levels from
dermal fibroblasts. Alternatively, PCR analysis may also be em-
ployed to look for collagen III mutations. Finally, it always helps to
consult a trained medical geneticist to assist with making the
diagnosis.
Dr B. Timothy Baxter (Omaha, Neb). I have a fair expe-
rience with these patients. I just have a couple comments and
questions.
I think that the older the patients are at the time they
present, the less I worry. I think their tissues are going to be
better if they present at an older age. The young patients are the
ones that the tissues can be more difficult. Can you comment on
this?
My other question is about surveillance in these patients. One
of the problems that you pointed out is that most of these are
women. I am reluctant to do frequent CT scans in these patients
because of the radiation risk especially associated with breast can-
cer. I have followed them with MRI.
The last question is, do you routinely do any intracranial
scanning to look for intracranial aneurysms or associated pathology
that might need to be addressed?
Dr Brooke. There is not a clear genotype-phenotype correla-
tion with Ehlers-Danlos syndrome, and patients of all ages and
subtypes can behave very differently in an operative setting. Older
patients with EDS who haven’t experienced a major vascular
complication may indeed have good tissue characteristics for elec-
tive procedures, but this is hard to generalize.
In our cohort, some of the oldest patients underwent the
endovascular procedures. Conversely, we worry that younger pa-
tients who present with vascular complications at an early age are
going to have poor tissue characteristics and may be at higher risk
for poor outcomes. We recognize that better methods are needed
for stratifying Ehlers-Danlos patients’ operative risk based on
variables including their age, comorbidities, family history, tissueWith regard to your second question about surveillance, we
employ a similar strategy that includes CT angiography, MRI/
MRA in special circumstances, and occasionally, ultrasound for
transcranial assessment.
We routinely assess intracranial imaging in patients when
the diagnosis of Ehlers-Danlos is in question. Patients with a
similar connective tissue disease known as Loeys-Dietz syn-
drome have a propensity for arterial tortuosity within their
vertebral and carotid vasculature. Hence, this radiographic find-
ing can help establish the diagnosis of Loeys-Dietz versus the
vascular type of Ehlers-Danlos.
Dr Ronald Dalman (Palo Alto, Calif). I noticed that most of
your patients that were treated were treated with embolization.
I’m curious how you approach more complex problems that don’t
necessarily lend themselves to embolization. For example, I have
one patient with distal internal carotid artery aneurysms fairly close
to the base of the skull plus a large renal artery aneurysm with a
history of spontaneous bleeding in the past. So if you’re not going
to use covered stents for those patients, what type of approaches do
you use in these more complex reconstructions, if you do consider
them?
Dr Brooke. We certainly try to use embolization or other
minimally invasive procedures in Ehlers-Danlos patients whenever
they are practical and amenable. Nevertheless, some patients are
only going to be candidates for an open repair due to their specific
anatomic variation or constrictions. Each operative approach is
dependent on the individual patient.
Dr Timothy Kresowik (Iowa City, Iowa). My first comment
relates to your suggested prohibition against the use of stent grafts
in Ehler-Danlos patients when you are treating a spontaneous
disruption rather than performing an aneurysm repair. If you have
a spontaneous disruption of a nonaneurysmal vessel, with good
landing zones, it seems like the stent graft is a much less invasive
and potentially more attractive approach.
Also, in your discussion of endovascular access, you talked
about the use of pledgets or other adjunctive reinforcements for
vessel repair. Are you implying that you always use an open
approach rather than a percutaneous approach? Do you think the
risk of complications is lower with an open approach or could it be
higher?
Dr James Black (Baltimore, Md). Let me clarify something
about the prior questions. I think in general, we agree that the
endovascular safety profile is quite good. I think a lot of that
speaks to lower-profile devices. The prior reports of mortality
rates of 20% to 40% even for a diagnostic arteriogram probably
were related to very large sheath sizes. So for Dr. Dalman’s
question, I think that the advent of newer technologies might
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cular technologies.
Now, on the other side of that, puncture site complications
are very common, and so it’s been our approach that particularly
for the patients that you know are quite fragile, multiple aneu-
rysms, very frequent rate of presentation with aneurysms, that
we do cut down on those femoral vessels. Most of those
procedures, as you might guess, are done under general anes-
thesia for all the concerns about accessing those vessels and
manipulating them.
And just to echo the prior issues of genotype-phenotype, we
have also appreciated that patients as they age, not necessarily
that they remain suitable for surgery, particularly on the vascular
EDS types, their average survival is only 48 years. So while they
might have handled the surgery very well at age 20 or 30, when
they come in again at age 40 and 50, well, they might be at the
end of their life expectancy, and their tissues could be more
fragile. So again, going back to the idea of a skilled medical
geneticist evaluating their tissues is clearly an important part of
our treatment paradigm.
Dr Gustavo Oderich (Rochester, Minn). One of your conclu-
sions was that we should be more liberal in the treatment indications
of aneurysms in patients with vascular EDS. And as you pointed out,
this is a very heterogenous group, and there are patients with more
vascular fragility than others. Sowhatwould you leave as amessage for
everybody here, what should be the indications?
I also have another question regarding the patients that you
didn’t treat, how many patients are you following with surveil-
lance only, and what is the fate of the aneurysms in those
patients?
Dr Black.Well, I think in general the study such as this, when
you talk about patients who are treated or not treated, we sufferwith the referral bias. And for genetic conditions in particular,
referral bias is a double-edged sword. Patients who havemild forms
of the disease, of course, are never referred at all, or they’re handled
in their local institution with relatively little morbidity, versus
patients who are tremendously affected and who probably aren’t
referred at all for the conception that they’re going to have a very
high rate of morbidity. So there is a group of patients that I think
we would have a hard time defining, referring to your question,
Gustavo.
And the other is just in general, a take-home message that
obviously this is – I don’t need to preach to the audience about
doing emergent procedures – but emergent procedures are inher-
ently more difficult. Your options become limited. Our treatment
will focus on patients who have an arterial abnormality that is chang-
ing, such as growing. Our results speak to a high percentage of
patients done electively versus the prior reports from theMayo Clinic
where 70% of the patients were done urgently. And I think that the
differences between our report and that report that’s available in the
Journal of Vascular Surgery are clearly related to that.
So I don’t think we want to ever defer an intervention on a
patient with EDS. If that aneurysm is growing, those patients, given
the window of time, can have a proper genetic evaluation, get a sense
about what the options are. As I said, with the advent of better
technologies, lower-profile, perhaps less traumatic,more flexible stent
grafts,maybe therewill be somewiggle room in the future to consider
stent-graft therapy, but that has not been our approach.
From the standpoint of stent-graft therapy for connective
tissue disorders, there is a pretty strong consensus statement.
Consensus statements actually carry somemedical-legal weight. So
it’s a very tricky ground to be traveling to say we’re going to put a
lot of stent grafts in these patients.
